Strategic Review of the Maryland Research and Development Tax Credit: Statutory Carryforward and Compliance Framework

The Credit Carryforward Period of seven taxable years allows Maryland businesses to apply unused Research and Development tax credits against future state income tax liabilities for up to seven years. This statutory window provides a mechanism for firms with low immediate tax liability to preserve the value of their innovation incentives until they achieve profitability.

The Maryland Research and Development (R&D) tax credit is a cornerstone of the state’s economic strategy, designed to foster a competitive environment for high-growth industries such as biotechnology, aerospace, and information technology. Under the authority of the Maryland Tax-General Code Annotated § 10-721, the state offers two distinct credits: the Basic R&D Tax Credit and the Growth R&D Tax Credit.1 While the statutory language defines these credits as a percentage of qualified research expenses (QREs), the actual fiscal benefit realized by a taxpayer is often governed by complex administrative mechanisms, specifically the carryforward provisions and annual budgetary caps.3 The seven-year carryforward period serves as a vital bridge for entities that operate at a loss during intensive research phases, ensuring that the state’s investment in private-sector innovation is not lost to the vagaries of a single tax year’s bottom line.1

Statutory Origin and Legal Evolution of the Carryforward

The legal framework for the R&D credit was established in 2000 and has undergone several legislative refinements to balance taxpayer incentives with state fiscal responsibility.3 A primary point of confusion for many practitioners is the duration of the carryforward. While current filings are subject to the seven-year rule, the Code of Maryland Regulations (COMAR) 03.04.10.08 retains a bifurcated standard based on the date of certification.6 For credits certified by the Department of Commerce before July 1, 2005, a fifteen-year carryforward was permitted; however, for all credits certified after June 30, 2005, the period was reduced to the current seven taxable years.6 This reduction reflects a broader legislative trend toward more frequent “recycling” of tax credits and preventing the accumulation of massive, multi-decade tax liabilities that could destabilize state revenue forecasts.8

The carryforward period begins the year after the taxable year in which the Maryland qualified research and development expense was incurred.1 It is important to distinguish between the “tax year of the expense” and the “year of the claim.” Because the certification process occurs in the calendar year following the expense, the first year of the seven-year clock effectively aligns with the first year the taxpayer has the certification letter in hand to attach to a return.1 Maryland law explicitly prohibits the “carryback” of these credits to preceding years, making the forward-looking strategy the only viable path for utilizing excess credit amounts.2

Administrative Guidance from the Department of Commerce

The Maryland Department of Commerce acts as the gatekeeper of the R&D credit, managing the application and certification lifecycle. Local state revenue office guidance emphasizes that the credit is not “claimed” in the traditional sense on an original return without prior state approval.2 Instead, a taxpayer must submit an application by November 15 of the calendar year following the tax year in which the expenses were incurred.1 The Department then has until February 15 of the subsequent year to issue a certification letter.4

This timeline creates a unique administrative requirement for carryforwards. Since the certification letter is often received after the filing deadline for the year the expenses were incurred, many taxpayers must file an amended return to “catch” the credit for that first year.1 If the credit cannot be fully absorbed by the tax liability in that amended year, the excess begins its seven-year journey through subsequent filings.9 The Department of Commerce guidance notes that for the purposes of the carryforward, the definition of a “taxable year” follows the taxpayer’s federal accounting period, which accommodates both calendar and fiscal year filers.10

The Comptroller’s Enforcement and Reporting Requirements

The Comptroller of Maryland oversees the actual utilization of the credits through the filing of Maryland Form 500CR for corporations or Form 502CR for individuals.2 For carryforwards to be valid, the Comptroller requires that the certification letter be attached to every return where a portion of the credit is claimed.1 Furthermore, for taxable years beginning after December 31, 2012, corporations claiming business tax credits, including the R&D carryforward, are generally required to file their returns electronically.12

Administrative Release No. 34 and subsequent guidance from the Comptroller clarify the treatment of these credits for tax-exempt organizations and pass-through entities (PTEs).13 While 501(c)(3) organizations can sometimes claim credits against withholding taxes, the R&D credit is primarily an income tax offset.13 For PTEs, such as S-corporations and LLCs, the entity itself does not use the carryforward; rather, the credit is passed through to the members via Schedule K-1.15 If a member’s share of the credit exceeds their individual tax liability, that member—not the entity—manages their own seven-year carryforward schedule.4 This creates a decentralization of the credit, where a single R&D project at the entity level can result in dozens of separate seven-year carryforward clocks across various individual and corporate members.15

Small Business Refundability vs. Corporate Carryforward

One of the most significant distinctions in Maryland’s R&D tax law is the treatment of small businesses. Under Tax-General § 10-721(d)(2), the seven-year carryforward is essentially bypassed for small businesses in favor of full refundability.1 A small business is defined as a for-profit entity with net book value assets totaling less than $5 million at either the beginning or the end of the taxable year in which the Maryland QREs were incurred.1

The “net book value” is a specific accounting metric defined as the cost of total assets (including intangibles) minus accumulated depreciation and amortization, without regard to liabilities.4 This definition is strictly enforced by the Department of Commerce, which requires the submission of a balance sheet to verify eligibility.4 For these qualifying small businesses, if the R&D credit exceeds the tax liability, the Comptroller issues a check for the difference rather than requiring the firm to track a carryforward.2 This reflects the state’s recognition that early-stage tech firms need liquidity more than future tax offsets.5

Proration Mechanics and the Erosion of Carryforward Value

A critical insight for business planning is that the statutory 10% Growth Credit is rarely the actual amount a company receives or carries forward. Maryland caps the total annual allocation of R&D credits at $12 million.4 Because the program is routinely oversubscribed—often by a factor of eight to ten—the Department of Commerce must prorate the credits.3

In the 2019 reporting cycle, businesses applied for over $117 million in combined R&D credits, while only $12 million was available.3 This led to a dramatic reduction in the “effective” credit rate. For a non-small business, the 10% Growth Credit was prorated down to an effective rate of approximately 1.18%.3 This proration is “irrevocable” for that tax year; the remaining “un-certified” portion of the applied-for credit cannot be carried forward.4 Only the certified amount that exceeds current tax liability enters the seven-year carryforward pool.1 Consequently, the seven-year window applies to a much smaller financial asset than many companies initially anticipate when budgeting for R&D.3

Corporate Successions: M&A and Asset Purchases

The portability of a seven-year carryforward is a key issue during corporate restructuring. Maryland generally follows federal guidelines under IRC § 381 and § 382 regarding the carryover of tax attributes.7 In a merger or a stock purchase where the legal entity survives, the R&D carryforward remains with the entity and can be used by the successor, subject to federal limitations on “ownership changes” that prevent “trafficking” in tax credits.9

However, Maryland guidance is explicit that in an asset purchase, the credits do not transfer.9 The credits are tied to the legal entity that incurred the expenses and received the certification. If a company sells its R&D assets but remains a legal entity, the carryforward stays with the seller.4 This nuance is vital for strategic real estate and expansion decisions, as the value of a carryforward must be priced into the structure of the deal.5 Furthermore, if a firm is acquired, the “Maryland Base Amount” (the historical average of R&D spending) of the acquired firm must be integrated into the new parent company’s calculations for future growth credits, which can actually make it harder to qualify for new credits in the short term.7

Compliance, Audit Defense, and Record Retention

The seven-year carryforward period necessitates a corresponding record retention policy that often exceeds the standard three-year statute of limitations for state audits. Because the Comptroller can challenge the validity of a carryforward in the year it is used, even if the credit was earned seven years prior, documentation must be preserved for the entire lifecycle of the credit.4

Maryland’s audit guidelines for R&D credits mirror the federal “Four-Part Test” found in IRC § 41.4 Taxpayers must maintain:

1. Technical Documentation: Project descriptions, lab notes, and prototypes demonstrating the elimination of technical uncertainty.4
2. Financial Substantiation: Payroll records linking specific employee hours to R&D projects, and detailed invoices for supplies used in Maryland.4
3. Gross Receipts Verification: Records of Maryland-sourced income for the four years preceding the credit year to justify the “Base Amount” calculation.4

The “Good Standing” requirement is another administrative hurdle; the Department of Commerce will not certify a credit if the business is not in good standing with the State Department of Assessments and Taxation (SDAT).11 A lapse in compliance during any year of the seven-year carryforward could potentially jeopardize the ability to apply the credit in that year.11

Calculation Methodology and the “Growth” Factor

The Growth R&D Tax Credit is the primary component that generates significant carryforwards for larger corporations. It is calculated as 10% of the Maryland QREs that exceed the “Maryland Base Amount”.9 The Base Amount is determined by multiplying the “fixed-base percentage” (the ratio of aggregate QREs to aggregate Maryland gross receipts for the prior four years) by the average annual Maryland gross receipts for the prior four years.4

For startup entities or firms that have not previously conducted R&D in Maryland, the law provides a “startup” base of zero.4 This allows 100% of the first year’s R&D expenses to qualify for the 10% Growth Credit (subject to proration), often resulting in a large initial credit that necessitates a carryforward in the company’s early, non-profitable years.4

If this company has a state tax liability of $50,000 and receives a prorated certification for $120,000 (after the state cap is applied), it would use $50,000 immediately and carry forward $70,000 into the first of its seven available future taxable years.1

Future Legislative Outlook and Program Sustainability

The Maryland R&D tax credit is currently set to remain available for taxable years beginning before 2026, with the program itself terminating on June 30, 2027, unless extended by the General Assembly.1 Recent evaluation reports by the Department of Legislative Services (DLS) suggest that the program is heavily utilized by the life sciences and manufacturing sectors, making reauthorization likely, though potentially with altered caps or eligibility rules.4

A significant emerging trend is the 2025 proposal for the “Income Tax Benefit Transfer Program” (HB 35).22 This legislation would allow companies with unused R&D carryforwards to sell those credits to other Maryland taxpayers.22 This would fundamentally change the meaning of the “seven-year period,” as the seven-year window would become a “trading window” for companies to monetize their credits if they do not expect to have sufficient tax liability to use them internally.22 This would align Maryland with states like New Jersey, which have pioneered the sale of tax benefits to support the cash flow of innovation-based startups.22

Conclusion and Strategic Recommendations

The Maryland Research and Development Tax Credit’s seven-year carryforward period is a vital component of the state’s fiscal framework for supporting innovation. While the law provides a seemingly straightforward ten-year horizon for pre-2005 credits and a seven-year window for modern ones, the interaction with annual proration and small business refundability adds layers of complexity that require diligent accounting. To maximize the value of this incentive, corporations must view the seven-year carryforward not merely as a passive tax attribute, but as a strategic asset that requires active management, comprehensive documentation for audit defense, and careful consideration during mergers and acquisitions. As the state nears the 2027 sunset of the current program and considers new transferability models, the ability to track and utilize these credits over the seven-taxable-year horizon will remain a critical determinant of the long-term ROI on Maryland-based research activities. Organizations are encouraged to align their state tax filings with federal substantiation standards to ensure that their seven-year carryforward remains secure against both administrative expiration and regulatory challenge.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/